## Abstract ## BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration
Elevated Secretory IgA Antibodies to Epstein-Barr Virus (EBV) and Presence of EBV DNA and EBV Receptors in Patients with Cervical Carcinoma
✍ Scribed by S.Y.Se Thoe; K.K. Wong; R. Pathmanathan; C.K. Sam; H.M. Cheng; U. Prasad
- Book ID
- 115615903
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 436 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background. We describe a case of a 16‐year‐old white girl with Epstein‐Barr virus (EBV)‐positive nasopharyngeal carcinoma (NPC). ## Methods. At diagnosis, the patient had characteristic immunoglobulin (Ig)A and IgG responses to EBNA1, viral capsid antigen (VCA)‐p18, and early ant
## Abstract Fifty‐six South Chinese individuals exhibiting IgA antibodies to EBV for 18 months and presenting naso‐pharyngeal abnormalities were biopsied. Four nasopha‐ryngeal carcinomas, two at a very early stage, were detected. In 14 further individuals, without clinical or his‐topathological evi